SCV-07: Phase II data

Top-line data from a double-blind, placebo-controlled, dose-ranging, U.S. Phase II trial in 59 head and neck cancer patients receiving chemotherapy showed that 0.1 mg/kg SCV-07 displayed a non-signifi...